Reducing the Time From Diagnosis to Treatment of Patients With Stage II/III Rectal Cancer at a Large Public Hospital.

Autor:	Hoffmann MS; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX mhoffmann@kumc.edu., Leslie LA; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX., Jacobs RW; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX., Millas S; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX., Surabhi V; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX., Mok H; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX., Jhaveri P; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX., Kott MM; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX., Jackson L; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX., Rieber A; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX., Bhadkamkar NA; University of Kansas Cancer Center, Overland Park, KS; John Theurer Cancer Center, Hackensack; Levine Cancer Center, Charlotte, NJ; The University of Texas at Houston; Baylor College of Medicine; Harris Health System; and The University of Texas MD Anderson Cancer Center, Houston, TX.
Jazyk:	angličtina
Zdroj:	Journal of oncology practice [J Oncol Pract] 2016 Feb; Vol. 12 (2), pp. e257-62.
DOI:	10.1200/JOP.2015.007484
Abstrakt:	Curative-intent therapy for stage II/III rectal cancer is necessarily complex. Current guidelines by the National Comprehensive Cancer Network recommend preoperative concurrent chemoradiation followed by resection and additional adjuvant chemotherapy. We used standard quality improvement methodology to implement a cost-effective intervention that reduced the time from diagnosis to treatment of patients with stage II/III rectal cancer by approximately 30% in a large public hospital in Houston, Texas. Implementation of the program resulted in a reduction in time from pathologic diagnosis to treatment of 29% overall, from 62 to 44 days. These gains were cost neutral and resulted from improvements in scheduling and coordination of care alone. Our results suggest that: (1) quality improvement methodology can be successfully applied to multidisciplinary cancer care, (2) effective interventions can be cost neutral, and (3) effective strategies can overcome complexities such as having multiple sites of care, high staff turnover, and resource limitations. (Copyright © 2016 by American Society of Clinical Oncology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu